Sovaldi Logo
Sept. 8, 2024
U.S. Food and Drug Administration Approves Gilead's Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C | Business Wire NCK Pharma » ZydusCadila to launch Gilead's Sovaldi in India Sovaldi / Совалди / Совальди (софосбувир) SOVALDI's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile | Sovaldi Logo